Skip to main content

Articles

Page 42 of 335

  1. Recent studies have shown the relevance of gut microbiota in the occurrence and development of colorectal cancer (CRC), but the causal relationship remains unclear in the human population. The present study ai...

    Authors: Jing-Jing Ni, Xiao-Song Li, Hong Zhang, Qian Xu, Xin-Tong Wei, Gui-Juan Feng, Min Zhao, Zi-Jia Zhang, Lei Zhang, Gen-Hai Shen and Bin Li
    Citation: BMC Cancer 2022 22:1371
  2. The gut microbiome plays an important role in immune modulation. Specifically, presence or absence of certain gut bacterial taxa has been associated with better antitumor immune responses. Furthermore, in tria...

    Authors: J. S. W. Borgers, F. H. Burgers, E. M. Terveer, M. E. van Leerdam, C. M. Korse, R. Kessels, C. C. Flohil, C. U. Blank, T. N. Schumacher, M. van Dijk, J. G. E. Henderickx, J. J. Keller, H. W. Verspaget, E. J. Kuijper and J. B. A. G. Haanen
    Citation: BMC Cancer 2022 22:1366
  3. In international guidelines, germline genetic testing is recommended for patients with metastatic prostate cancer. Before undergoing germline genetic testing, these patients should receive pre-test counseling....

    Authors: Michiel Vlaming, Eveline M. A. Bleiker, Inge M. van Oort, Lambertus A. L. M. Kiemeney and Margreet G. E. M. Ausems
    Citation: BMC Cancer 2022 22:1365
  4. Uterine corpus endometrial carcinoma (UCEC) is the most common female pelvic malignancy worldwide. N6-methyladenosine (m6A) plays an important role in various cellular responses, especially in cancer progression....

    Authors: Fang Fang, Peipei Wang, Haoyu Huang, Mingquan Ye, Xiaocen Liu and Qingqing Li
    Citation: BMC Cancer 2022 22:1364
  5. Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic) pancreatic ductal adenocarcinoma (PDAC). These pa...

    Authors: D. Doppenberg, M. G. Besselink, C. H. J. van Eijck, M. P. W. Intven, B. Groot Koerkamp, G. Kazemier, H. W. M. van Laarhoven, M. Meijerink, I. Q. Molenaar, J. J. M. E. Nuyttens, R. van Os, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, E. Versteijne, J. W. Wilmink…
    Citation: BMC Cancer 2022 22:1363

    The Correction to this article has been published in BMC Cancer 2023 23:70

  6. Clear cell carcinoma is an uncommon histologic subtype of ovarian and endometrial carcinoma with poor response to Platinium-based chemotherapy agents at high stages. Blockage of Programmed cell Death Ligand-1 ...

    Authors: Dorsa Ghasemi, Fereshteh Ameli, Fatemeh Nili, Ramtin Edjtemaei and Shahrzad Sheikhhasani
    Citation: BMC Cancer 2022 22:1362
  7. Research on the impact of metabolic abnormalities on breast cancer prognosis is limited by small samples and assessment of laboratory values at a single time point, often prior to cancer diagnosis and treatmen...

    Authors: Alexa S. Zimbalist, Bette J. Caan, Wendy Y. Chen, Elizabeth A. Mittendorf, Deborah A. R. Dillon, Charles Quesenberry and Elizabeth M. Cespedes Feliciano
    Citation: BMC Cancer 2022 22:1361
  8. Brain cancer is one of the most aggressive cancer types owing to poor treatment effects. Epidemiological studies have demonstrated that allergies may increase the disease risk. Therefore, this study evaluated ...

    Authors: Yun Zhu, Yirong Teng, Shuangyan Xu, Yinde Xu, Boheng Zhu, Weimin Yan and Jie Liu
    Citation: BMC Cancer 2022 22:1360
  9. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) and T cell/histiocyte-rich large B-cell lymphoma (THRLBCL) have overlapping histological features that make their diagnosis challenging. Insulin-like gro...

    Authors: Farid Kosari, Trifeh Bakhshi, Fereshteh Ameli and Maral Mokhtari
    Citation: BMC Cancer 2022 22:1359
  10. Preoperative sarcopenia is a predictor of poor survival in cancer patients. We hypothesized that sarcopenia could progress as occult metastasis arose, especially after highly invasive surgery for highly aggres...

    Authors: Sho Yasuta, Motokazu Sugimoto, Masashi Kudo, Shin Kobayashi, Shinichiro Takahashi, Masaru Konishi and Naoto Gotohda
    Citation: BMC Cancer 2022 22:1358
  11. The combination of taxanes and anthracyclines is still the mainstay of chemotherapy for early breast cancer. Capecitabine is an active drug with a favorable toxicity profile, showing strong anti-tumor activity...

    Authors: Houpu Yang, Ling Xu, Shan Guan, Xiaopeng Hao, Zhicheng Ge, Fuzhong Tong, Yingming Cao, Peng Liu, Bo Zhou, Lin Cheng, Miao Liu, Hongjun Liu, Fei Xie, Siyuan Wang, Yuan Peng, Chaobin Wang…
    Citation: BMC Cancer 2022 22:1357
  12. Since the publication of MA-20 and EORTC-22922 trials, chest wall (CW)/ whole breast (WB) irradiation + comprehensive regional nodal irradiation (RNI) with internal mammary node irradiation (IMNI) has been the...

    Authors: Wei-Xiang Qi, Lu Cao, Siyue Zheng, Cheng Xu, Rong Cai, Haoping Xu, Gang Cai and Jiayi Chen
    Citation: BMC Cancer 2022 22:1356
  13. Molecule interacting with CasL 1 (MICAL1), a multidomain flavoprotein monooxygenase, is strongly involved in the biological processes related to cancer cell proliferation and metastasis. However, there were fe...

    Authors: Yixing Yang, Fengwen Ye, Tianxiang Xia, Qianwen Wang and Jun Du
    Citation: BMC Cancer 2022 22:1355
  14. In our previous study it was found that CENPL was overexpressed in hepatocellular carcinoma and significantly predicted patient's prognosis. However, the expression and prognostic value of CENPL in other gastroin...

    Authors: Zhongyuan Cui, Ling Du, Jielong Wang, Zhongzhuan Li, Jiehong Xu, Shiyu Ou, Dongliang Li, Shasha Li, Hanfang Hu, Gang Chen and Zhixian Wu
    Citation: BMC Cancer 2022 22:1354

    The Correction to this article has been published in BMC Cancer 2023 23:12

  15. Women living with metastatic breast cancer (MBC) are at risk of significantly impaired quality of life (QOL), symptom burden, distress and fear of progression, and unmet needs, yet they face barriers to access...

    Authors: Lisa Beatty, Emma Kemp, Phyllis Butow, Afaf Girgis, Nicholas Hulbert-Williams, Billingsley Kaambwa, Penelope Schofield, Jane Turner, Richard Woodman, Frances Boyle, Anthony Daly, Amanda Jones, Belinda Kiely, Nicholas Zdenkowski and Bogda Koczwara
    Citation: BMC Cancer 2022 22:1353
  16. Penile cancer is a rare disease in demand for new therapeutic options. Frequently used combination chemotherapy with 5 fluorouracil (5-FU) and cisplatin (CDDP) in patients with metastatic penile cancer mostly ...

    Authors: Ria Winkelmann, Katrin Bankov, Claudia Döring, Jaroslav Cinatl, Sebastian Grothe, Florian Rothweiler, Martin Michaelis, Christina Schmitt, Peter J. Wild, Melanie Demes, Jindrich Cinatl Jr. and Stefan Vallo
    Citation: BMC Cancer 2022 22:1352
  17. Glioma-initiating cells (GICs) are the source of glioma cells that can self-renew, have pluripotency, and are treatment-resistant, so are the starting point for relapse and eventual death despite multimodality...

    Authors: Kiyotaka Yokogami, Taisei Kikuchi, Takashi Watanabe, Yasutaka Nakatake, Shinji Yamashita, Asako Mizuguchi and Hideo Takeshima
    Citation: BMC Cancer 2022 22:1351
  18. Metastatic castration-resistant prostate cancer (mCRPC) is a lethal form of prostate cancer, and the molecular mechanism driving mCRPC progression has not yet been fully elucidated. Immunotherapies such as chi...

    Authors: Xiaolu Cui, Hongyuan Yu, Jinlong Yao, Jinling Li, Zhenhua Li and Zhenming Jiang
    Citation: BMC Cancer 2022 22:1350
  19. Several studies showed that lack of CD56 expression was a poor prognostic factor for patients with newly diagnosed multiple myeloma (NDMM). However, other studies were not able to confirm the prognostic value ...

    Authors: Chuanying Geng, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Guangzhong Yang and Wenming Chen
    Citation: BMC Cancer 2022 22:1349
  20. Authors: Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi…
    Citation: BMC Cancer 2022 22:1348

    The original article was published in BMC Cancer 2022 22:960

  21. Excision repair cross-complementation group 6 like (ERCC6L), a polo-like kinase 1 (PLK1)-interacting checkpoint helicase, confers a high risk of cancer and enhances the progression of a variety of cancers. The...

    Authors: Zhimin Lu, Lihong Fei and Guoxin Hou
    Citation: BMC Cancer 2022 22:1347
  22. Although neuroendocrine tumors (NET) are classed as rare, they have a high prevalence and their incidence is increasing. Effective treatment with lutetium 17-[177Lu]Lu-oxodotreotide (Lutathera®) is possible in pa...

    Authors: Emmanuel Deshayes, Eric Assenat, Laetitia Meignant, Manuel Bardiès, Lore Santoro and Sophie Gourgou
    Citation: BMC Cancer 2022 22:1346
  23. The failure of current chemotherapeutic agents for pancreatic cancer (PCa) makes it the most aggressive soft tissue tumor with a 5-year survival of slightly above 10% and is estimated to be the second leading ...

    Authors: Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu and Edward Agyare
    Citation: BMC Cancer 2022 22:1345
  24. Exosomes play an important role in the tumor microenvironment (TME) and the mechanisms of tumor immune escape in hepatocellular carcinoma (HCC). It is known that immunosuppressive genes, involved in the proces...

    Authors: Zhan Yang, Xinmiao Li, Chaoran Pan, Yifei Li, Lifan Lin, Yan Jin, Jianjian Zheng and Zhengping Yu
    Citation: BMC Cancer 2022 22:1344
  25. In clinical trials, poly (ADP-ribose) polymerase inhibitors (PARPi) versus chemotherapy resulted in significantly improved progression-free survival, manageable adverse event profiles, and favorable patient-re...

    Authors: Reshma Mahtani, Alexander Niyazov, Bhakti Arondekar, Katie Lewis, Alex Rider, Lucy Massey and Michael Patrick Lux
    Citation: BMC Cancer 2022 22:1343
  26. Other iatrogenic immunodeficiency-associated (OIIA) T- and natural killer (NK)-cell lymphoproliferative disorders (TNK-LPDs) are rare in patients with rheumatoid arthritis (RA).

    Authors: Shoichi Kimura, Yumi Oshiro, Hiromi Iwasaki, Masanori Kadowaki, Masao Ogata, Tsutomu Daa, Toshifumi Sakata, Shigeto Kawauchi, Ziyao Wang, Yasushi Takamatsu and Morishige Takeshita
    Citation: BMC Cancer 2022 22:1342
  27. Prostate cancer is a public health problem and increasingly diagnosed in men under 50 years of age. This cancer occurs much more in subjects of advanced age, generally over sixty. The aim of the study was to d...

    Authors: Tchin Darré, Toukilnan Djiwa, Tchilabalo Matchonna Kpatcha, Essodina Padja, Gado Napo-Koura and Tchin DARRE
    Citation: BMC Cancer 2022 22:1341
  28. Many cytogenetic changes and gene mutations are associated with acute myeloid leukemia (AML) survival outcomes. CD56 is related to poor prognosis when expressed in adult AML patients. However, the prognostic v...

    Authors: Tianqi Liang, Zhiyong Peng, Chunfu Li, Junbin Huang, Huabin Wang, Chaoke Bu, Jian Li, Yongzhi Zheng, Xiaoqin Feng, Huiping Li and Chun Chen
    Citation: BMC Cancer 2022 22:1339
  29. HERPUD1 is an important early marker of endoplasmic reticulum stress (ERS) and is involved in the ubiquitination and degradation of several unfolded proteins. However, its role in tumorigenesis is seldom studi...

    Authors: Xin Nie, Dawo Liu, Mingjun Zheng, Xiao Li, Ouxuan Liu, Qian Guo, Liancheng Zhu and Bei Lin
    Citation: BMC Cancer 2022 22:1338
  30. Recurrent/ metastatic squamous cell carcinoma of head and neck (R/M SCCNH) is still a difficult-to-treat disease with poor clinical outcomes and limited treatment choices. In view of locoregional recurrent ver...

    Authors: Tien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, Ling-Wei Wang, Shyh-Kuan Tai, Pen-Yuan Chu, Wen-Liang Lo, Cheng-Hsien Wu, Muh-Hwa Yang and Peter Mu-Hsin Chang
    Citation: BMC Cancer 2022 22:1336
  31. The chemokines, CXCL12 and CXCL11, are upregulated in tumors from many organs and control their progression. CXCL12 and CXCL11 affect tumor cell functions by either binding their prime receptors, CXCR4 and CXC...

    Authors: Christian Koch, Nina Charlotte Fischer, Malte Puchert and Jürgen Engele
    Citation: BMC Cancer 2022 22:1335

    The Correction to this article has been published in BMC Cancer 2023 23:769

  32. Although endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure, fatal infectious complications have been reported. However, adequate preventive strategi...

    Authors: Na Young Kim, Jae Hyeon Park, Jimyung Park, Nakwon Kwak, Sun Mi Choi, Young Sik Park, Chang-Hoon Lee and Jaeyoung Cho
    Citation: BMC Cancer 2022 22:1334

    The Correction to this article has been published in BMC Cancer 2023 23:75

  33. Globally, the burden of endometrial endometrioid carcinoma (EEC) increases annually. However, the histological grade of EEC remains unelucidated. We developed a novel model for predicting lymph node metastasis...

    Authors: Xingdan Guo, Chunhua Lin, Jing Zhao and Mi Tang
    Citation: BMC Cancer 2022 22:1333
  34. FOXO1 transcription factor not only limits the cell cycle progression but also promotes cell death as a tumor suppressor protein. Though the expression of FOXO1 is largely examined in breast cancer, the regula...

    Authors: Avishek Kar, Kanchan Kumari, Sandip K. Mishra and Umakanta Subudhi
    Citation: BMC Cancer 2022 22:1332
  35. Although the prognosis of locally advanced cervical cancer has improved dramatically, survival for those with stage IIIB-IVA disease or lymph nodes metastasis remains poor. It is believed that the incorporatio...

    Authors: Gong-yi Zhang, Rong Zhang, Ping Bai, Shu-min Li, Yuan-yuan Zhang, Yi-ran Chen, Man-ni Huang and Ling-ying Wu
    Citation: BMC Cancer 2022 22:1331
  36. Despite the higher burden of cervical cases, screening programs in highly affected developing countries remained low. This made the disease to be present at an advanced stage which is almost always fatal, caus...

    Authors: Tilahun Assefa, Mastewal Arefaynie, Wondwosen Mebratu, Anissa Mohammed, Elsabeth Addisu and Natnael Kebede
    Citation: BMC Cancer 2022 22:1330
  37. Lymphovascular invasion (LVI) is a factor correlated with a poor prognosis in oesophageal squamous cell carcinoma (ESCC). Lymphatic invasion (LI) and vascular invasion (VI) should be reported separately becaus...

    Authors: An Wang, Yulong Tan, Shaohua Wang and Xiaofeng Chen
    Citation: BMC Cancer 2022 22:1329
  38. The malignant behaviors of lung cancers are affected by not only cancer cells but also many kinds of stromal cells in tumor microenvironment (TME), including macrophages. Macrophages have been proven to extens...

    Authors: Yuexin Zhang, Ziqi Zhang, Lei Chen and Xiuyue Zhang
    Citation: BMC Cancer 2022 22:1327
  39. Osteosarcoma is the most common bone tumor in children and adolescents. Despite multiagent chemotherapy, only 71% of patients survives and these survivors often experience long-term toxicities. The main object...

    Authors: Evelien G. E. Hurkmans, Annouk C. A. M. Brand, Job A. J. Verdonschot, D. Maroeska W. M. te Loo and Marieke J. H. Coenen
    Citation: BMC Cancer 2022 22:1326
  40. Biomarkers that can accurately predict the efficacy of immune checkpoint inhibitors (ICIs) against programmed death 1 (PD-1) ligand in cancer immunotherapy are urgently needed. We have previously reported a no...

    Authors: Ou Yamaguchi, Kazuyuki Atarashi, Kenichi Yoshimura, Ayako Shiono, Atsuhito Mouri, Fuyumi Nishihara, Yu Miura, Kosuke Hashimoto, Yoshiaki Miyamoto, Hitoshi Uga, Nobuo Seki, Tomoko Matsushima, Norihiro Kikukawa, Kunihiko Kobayashi, Kyoichi Kaira and Hiroshi Kagamu
    Citation: BMC Cancer 2022 22:1325
  41. Oesophageal and gastrooesophageal junction (GOJ) carcinoma frequently present with dysphagia and de novo metastatic disease. There is scope to improve treatment paradigms to both address symptoms and improve s...

    Authors: Fiona Day, Swetha Sridharan, James Lynam, Craig Gedye, Catherine Johnson, Allison Fraser, Stephen R. Thompson, Michael Michael, Trevor Leong, Amitesh Roy, Mahesh Kumar, Andre van der Westhuizen, Gaik T. Quah, Hiren Mandaliya, Girish Mallesara, Joshua Sappiatzer…
    Citation: BMC Cancer 2022 22:1324
  42. Epidermal growth factor receptor (EGFR) amplification refers to the copy number increase of EGFR gene, and is often identified as a “bypass” way of Epidermal growth factor receptor Tyrosine kinase inhibitors (...

    Authors: Duanyang Peng, Pingan Liang, Congying Zhong, Peng Xu, Yanqing He, Yuxi Luo, Xia Wang, Anwen Liu and Zhimin Zeng
    Citation: BMC Cancer 2022 22:1323
  43. Although initial therapy with a parenteral anticoagulant is required before edoxaban, this strategy is frequently avoided in actual clinical practice because of its complexity. This study assessed the feasibil...

    Authors: Michio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, Yasuyuki Kawamoto, Satoshi Yuki, Susumu Sogabe, Ayumu Hosokawa, Kentaro Sawada, Osamu Muto, Naoki Izawa, Koji Nakashima, Yoshiki Horie, Masataka Yagisawa, Shinya Kajiura, Takayuki Ando, Yosuke Mitsuhashi…
    Citation: BMC Cancer 2022 22:1322
  44. Patients with BRAF V600E mutated metastatic colorectal cancer (mCRC) have a poor prognosis. The introduction of BRAF targeted therapy with encorafenib and weekly administered cetuximab have shown improved surv...

    Authors: Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, Christina Westmose Yde, Lone Nørgård Petersen, Laurids Østergaard Poulsen and Camilla Qvortrup
    Citation: BMC Cancer 2022 22:1321
  45. Research infrastructures such as biorepositories are essential to facilitate genomics and its growing applications in health research and translational medicine in Africa. Using a cervical cancer cohort, this ...

    Authors: Oppah Kuguyo, Nyasha Chambwe, Charles F. B. Nhachi, Nomsa Tsikai, Collet Dandara and Alice Matimba
    Citation: BMC Cancer 2022 22:1320
  46. Galectin-9 is a member of the galectin family and has been reported to have a tumor-promoting or antitumor effect in response to the immune microenvironment. However, the immunomodulatory effect of galectin-9 ...

    Authors: Yang Wang, Ruizhi Zheng, Yanhui Zhang, Yuhong Guo, Zhenzhen Hui, Peijing Wang and Yan Sun
    Citation: BMC Cancer 2022 22:1319
  47. Acquired chemo-drug resistance constantly led to the failure of chemotherapy for malignant cancers, consequently causing cancer relapse. Hence, identifying the biomarker of drug resistance is vital to improve ...

    Authors: Rui Zeng, Hua Li, Lingyan Jia, Sau Har Lee, Rilei Jiang, Yujia Zhang, Xudong Hu, Tingjie Ye, Xiaoling Wang, Xiaofeng Yan, Yanlin Lu, Zhumei Sun, Jiatuo Xu and Wei Xu
    Citation: BMC Cancer 2022 22:1317

Featured videos

View featured videos from across the BMC-series journals